People · Operator
Named in public records as an officer, director or promoter · active 2016–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Epiodyne, Inc. | — | Biotechnology | Series A | $14.3M | $289.2M | 2016 |
| Deep Apple Therapeutics, Inc. | — | Biotechnology | Series A | $5.0M | $90.7M | 2021 |
Brian Shoichet at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian Shoichet on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Seth Harrison | 1 | 19 |
| Brook Byers | 1 | 13 |
| Douglas Crawford | 1 | 8 |
| Michael Ehlers | 1 | 6 |
| Spiros Liras | 1 | 6 |
| Paul Da Silva Jardine | 1 | 3 |
| Alex Tkachenko | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.